![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.00 | 15.50 | 16.50 | 16.00 | 16.00 | 16.00 | 38,250 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 5.63 | 14.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/8/2017 15:37 | Sienna - It could be. We can only guess. Another advantage may indeed be the cost effectiveness and consequently margins of sticking with the same organization. However, relying on one company for all world markets? Really? All along SOH has banged on about reducing risk. If this agreement doesn't go well then where does that leave OptiBiotix? On the starting grid again is what I'd suggest. As I previously said, I'm also skeptical because Sacco on the face of it appear to have contacts in Europe, but Asia, USA and the rest of the world? There's been no mention of that before or even in today's RNS. Surely there are other organizations far better placed in these regions? Finally, most tellingly, is that there is no mention re: revenues already generated via Sacco? Where are those interims? Why does SOH deem it necessary to conduct an interview after every RNS? All the hallmarks of an imminent cash raise imho. Aimho of course. | ![]() michaelmouse | |
22/8/2017 15:31 | ...How can the Interims be in October? Their half year runs from end November to end May. Aim rules state that the half year results have to be released within three months of the period end - unless the rules have changed recently? | ![]() someuwin | |
22/8/2017 15:18 | Fincap note: "LP-LDL agreement for US and ROW CORP OptiBiotix (OPTI) has announced the signing of a new supply agreement with Sacco to cover sales of LP-LDL into the USA and Rest of the World (ROW), in return for a 50% profit share, as well as extending the use of LPLDL into dairy applications. This new agreement builds upon the earlier supply and manufacturing agreement signed in March (European supply only) and significantly expands the commercial potential for LP-LDL in light of Sacco’s strong global distributor network. We keep our forecasts UR at this time pending greater clarity on revenue forecasts but note that this agreement signifies a significant strategic step for OPTI to access the billion dollar US probiotic supplement market. LP-LDL potentially a global brand with underlying science to support claims of improved cardiovascular health and reduced cholesterol in subjects who use products to aid healthy living. Sacco has given a commitment to support further development of LP-LDL which includes marketing and human studies. Sacco partnership extension is a strong corporate agreement with a supplier and manufacturer with a global network of distributors. Sourcing of finished products from multiple locations should diversify commercial risk, secure future supply chains and utilises economies of scale to increase margins. Expansion of LP-LDL into dairy aims to allow LP-LDL into the $36bn probiotic dairy market. With Sacco already one of Europe’s leading probiotic manufacturers (suppling over 2,500 businesses), OPTI also have commitment for further product development to expand commercialisation further still. Commercial development continues with OPTI once again expanding and paving crucial relationships with key third parties in order to realise product potential. We remain encouraged by management’s progress so far and the extension both geographically and commercially (into dairy), of their existing with Sacco." Also notes Interims in October. | andyhayward1990 | |
22/8/2017 15:02 | I don't think they'll put the results out on Friday. And Monday is Bank Holiday, so results will either be out in the next two days or Tues / Wed / Thur next week. | ![]() someuwin | |
22/8/2017 14:47 | Strange that we aren't higher; can sell 60k above the current sp | ![]() f3rdinand | |
22/8/2017 14:02 | News in the weeks and months ahead. So todays release is in the weeks ahead category and this is the second time this has happened. Now we have the results due and posible contract news from some of the interested parties. And delayed reaction to today's news could mean that anyone selling would have to pay more to get back in. | ![]() bobdown2 | |
22/8/2017 13:59 | M'Mouse is hell bent on doing his best to turn people off with clouding reality with his own made up negative stance. He would be best placed and better served and time better spent to get out of his AVN, TRAK AND STYLO shares, all duds and put his cash into OPTI. He says plenty on here, wasting his time on a share he does not hold either long or short. Personally never understood why someone would be so interested and talk about a share of which there is no investment holding. I wonder if he feels any remorse and pity, for the poor people who may have invested in those aforementioned shares, based on his poor recommendations, via his ramblings on the bb's and his cheeky and useless personal blog. The sheer audacity of the RAMPER, MICHAELMOUSE in saying that TRAK will get to £20, oh dear.AIMHO, of course. | ![]() lukead | |
22/8/2017 13:55 | The same peoeple will be buyig at higher price in a few months time. It's the way herd mentality works and its how 'clever' people have been able to rule the herd for centuries. | divinessence | |
22/8/2017 13:25 | Absolutely fantastic news today, it's a shame some people don't see the bigger picture (with all the sells)! I also listened to the interview and SOH seems very confident! | ![]() primal123 | |
22/8/2017 13:12 | Parob, also sounds like Sacco have talked with their clients to establish interest prior to this announcement. | ![]() rafboy | |
22/8/2017 12:54 | Elrico, thanks for clarification. I can see where you are coming from. | ![]() rafboy | |
22/8/2017 12:46 | So from SOH in the interview:Having a single manufacturer helps simplify negotiations, especially with large corporates. Sounds like lots of dairy opportunities in the Asian market... | ![]() parob | |
22/8/2017 12:43 | Raf - Red SBTX. It is just my opinion. My logic is, that expect positive news in on the coming months which should assist with a progressive rise which may be helped as OPTI progresses and demonstrates the business model and corporate strategy. | elrico | |
22/8/2017 12:37 | And here's SOH's interview just out! | ![]() parob | |
22/8/2017 12:18 | Elrico, in one of your recents posts you summised that the SBTX distribution might not take place until the SBTX market cap/share price was higher than the current share price by a margin of 2 or 3. Excuse my ignorance, is it your opinion that the SBTX share price may need to rise by more than 100% before such share distribution takes place? I appreciate this is is just your personal view by the way or am I way off beam? | ![]() rafboy | |
22/8/2017 12:14 | 2. Extension of LP(LDL) (R) into dairy applications utilising Sacco's network in the dairy industry to develop commercial opportunities identified by them in the global $35.5 billion probiotic dairy marketIf we're not in discussions with them already, I'm sure Benecol will be taking note of today's RNS. Quite a few media outlets have covered today's news and I expect more coverage as the news filters through to trade magazines.I wonder if we'll see a combination product of plant sterols with LP-LDL in the future for even better results? | ![]() parob | |
22/8/2017 11:53 | Per is offering a big clue a dairy related deal is in the pipeline. All in my humble opinion of course: ) | elrico | |
22/8/2017 11:45 | parob, like I said this agreement would have needed to be in place (in fact critical) prior to rolling out other licenses. its still been missed by many but for me its a massive tell tale sign of whats to come. the next few weeks and months could get very interesting. they've barely mentioned the US much but it look slike its game on for whichever companies are fighting it out for exclusive rights!! s | ![]() shrewdmole | |
22/8/2017 11:33 | Per Rehné status update on Linkedin:Per Rehné Commercial Director and Board Member at OPTIBIOTIX HEALTH PLC 1h As a result of our cooperation with Sacco and their excellent performance we have today announced a global agreement with Sacco and the extension in to Dairy Applications with the Focus on Functional Dairy which opens the opportunity for the consumer to maintain healthy Cholesterol levels through their daily dairy intake. This also means a strengthened promotional presence in the US and ROW which will help to speed up the commercialisation process. We are pleased and excited about this extension of our cooperation with Sacco. | ![]() parob | |
22/8/2017 11:22 | Can you believe it elrico .. "Just a family run business" "Just googled them and got nothing" Actually .. just thinking .. maybe I shouldn't encourage them to come on here :O/ | ![]() onedayrodders | |
22/8/2017 11:22 | Clue - MMs soaking up sellers orders. One of many exciting RNS to come IMO.This is one to tuck away long-term.Excellent business model for AIM company with very little risk IMO. | ![]() vanduke | |
22/8/2017 11:20 | I have been mostly buying over the past few days.Upwards and onwards. | ![]() vanduke | |
22/8/2017 11:18 | From Michaelmouse post 1818...."In fact, it is clear from the previous RNS that they couldn't agree terms with any other organization to address these large markets and have had to stick with their European partner"It seems you are trying to insinuate that no other organisation wanted to run with the product!But...Could it not just as easily be that these other organisations were unable to agree terms as attractive as the ones agreed with Sacco (I mean 50% profit share is pretty damn good in my book - along with the other terms) and so Opti went for the better option? Isn't that what Opti should be doing?Sienna | ![]() siennadelekat21 | |
22/8/2017 11:05 | ODR - stiff competition for BBM of year on the other thread: ) | elrico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions